Inventor · disambiguated record
Donald Mcafee
Also filed as: MCAFEE DONALD · MCAFEE DONALD A
11 granted patents·1 pending application·246 citations·filing 1990–2020
91Inventor score
Files withWHITBY RESEARCH INC4AEQUUS PHARMACEUTICALS INC3DISCOVERY THERAPEUTICS INC3ALPHA TO OMEGA PHARMACEUTICAL CONSULTANTS INC2
Top patents by PatentIndex Score
12 records- 0189US6339072B2Compositions and methods for preventing restenosis following revascularization proceduresDISCOVERY THERAPEUTICS INC·Filed 2001·Granted Jan 15, 2002·43 cites·15 claims
- 0287US5206377ACompounds useful as antiproliferative agentsWHITBY RESEARCH INC·Filed 1991·Granted Apr 27, 1993·61 cites·8 claims
- 0386US5314908ACompounds useful as antiproliferative agentsWHITBY RESEARCH INC·Filed 1992·Granted May 24, 1994·30 cites·14 claims
- 0476US5117830AMethod of determining viability of tissueWHITBY RESEARCH INC·Filed 1990·Granted Jun 2, 1992·51 cites·21 claims
- 0569US10500196B2Transdermal and/or topical delivery systems composed of doxylamine succinate and pyridoxine hydrochloride in combination, or aloneAEQUUS PHARMACEUTICALS INC·Filed 2016·Granted Dec 10, 2019·1 cites·10 claims
- 0668US10624901B2Transdermal and/or topical delivery system comprising clobazamALPHA TO OMEGA PHARMACEUTICAL CONSULTANTS INC·Filed 2019·Granted Apr 21, 2020·0 cites·16 claims
- 0766US5256398AComposition for determining viability of tissueWHITBY RESEARCH INC·Filed 1992·Granted Oct 26, 1993·25 cites·12 claims
- 0860US11717525B2Transdermal and/or topical delivery system comprising clobazamALPHA TO OMEGA PHARMACEUTICAL CONSULTANTS INC·Filed 2020·Granted Aug 8, 2023·0 cites·18 claims
- 0955US6372723B1Compositions and methods for preventing restenosis following revascularization proceduresDISCOVERY THERAPEUTICS INC·Filed 1999·Granted Apr 16, 2002·16 cites·16 claims
- 1053US5477857ADiagnostic uses of hydrazinoadenosinesDISCOVERY THERAPEUTICS INC·Filed 1993·Granted Dec 26, 1995·19 cites·4 claims
- 1152US10449201B2Transdermal and/or topical delivery system comprising clobazamAEQUUS PHARMACEUTICALS INC·Filed 2016·Granted Oct 22, 2019·0 cites·15 claims
- 1246US2018250281A1Transdermal delivery of doxylamine succinate and pyridoxine hydrochlorideAEQUUS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →